Department of Surgery, The Johns Hopkins School of Medicine, Baltimore, MD; Department of Surgery, NYU Grossman School of Medicine, New York, NY.
Department of Surgery, The Johns Hopkins School of Medicine, Baltimore, MD.
Curr Probl Diagn Radiol. 2022 Nov-Dec;51(6):878-883. doi: 10.1067/j.cpradiol.2022.04.001. Epub 2022 Apr 22.
Pancreatic ductal adenocarcinoma is the third-leading cause of all cancer-related deaths in the US. While 20% of patients have resectable disease at diagnosis, improved control of systemic disease using effective chemotherapeutic regimens allows for aggressive operations involving complex vascular resection and reconstruction. A pancreas protocol computed tomography (PPCT) is the gold standard imaging modality in determining local resectability (degree of tumor-vessel involvement), however, it is limited by the inter-operator variability. While post-processing-3D-rendering helps, it does not allow for real-time dynamic assessment of resectability. A recent development in post-process-rendering called cinematic rendering (CR) overcomes this by utilizing advanced light modeling to generate photorealistic 3D images with enhanced details. Cinematic rendering allows for nuanced visualization of areas of interest. Our preliminary experience, as one of the first centers to incorporate the routine use of CR, has proven very useful in surgical planning. For local determination of resectability, vascular mapping allows for accurate assessment of major arteries and the portovenous system. For the portovenous anatomy it assists in determining the optimal surgical approach (extent of resection, appropriate technique for reconstruction, and need for mesocaval shunting). For arterial anatomy, vessel encasement either represents dissectible involvement via periadventitial dissection or true vessel invasion that is unresectable. CR could potentially provide superior ability than traditional PPCT to discern between the two. Additionally, CR allows for better 3D visualization of arterial anatomic variants which, if not appreciated preoperatively, increases risk of intraoperative ischemia and postoperative complications. Lastly, CR could help avoid unnecessary surgery by enhanced identification of occult metastatic disease that is metastatic disease that is otherwise not appreciated on a standard PPCT.
胰腺导管腺癌是美国所有癌症相关死亡的第三大原因。虽然 20%的患者在诊断时存在可切除的疾病,但通过使用有效的化疗方案控制全身疾病,可进行涉及复杂血管切除和重建的积极手术。胰腺方案 CT(PPCT)是确定局部可切除性(肿瘤-血管受累程度)的金标准成像方式,但它受到操作者间变异性的限制。虽然后处理 3D 渲染有助于提高准确性,但它不允许实时动态评估可切除性。最近在后处理渲染方面的一项发展,称为电影渲染(CR),通过利用先进的光照建模来生成具有增强细节的逼真 3D 图像,克服了这一问题。电影渲染允许对感兴趣的区域进行细致的可视化。作为首批常规使用 CR 的中心之一,我们的初步经验证明,它在手术计划中非常有用。对于局部可切除性的确定,血管绘图可准确评估主要动脉和门静脉系统。对于门静脉解剖结构,它有助于确定最佳手术入路(切除范围、适当的重建技术以及是否需要肠系膜腔分流术)。对于动脉解剖结构,血管包埋要么代表通过血管外膜剥离术可分离的受累,要么代表不可切除的真正血管侵犯。CR 有可能比传统的 PPCT 提供更好的区分两者的能力。此外,CR 可以更好地显示动脉解剖变异,如果术前没有意识到这些变异,会增加术中缺血和术后并发症的风险。最后,CR 通过增强对标准 PPCT 上未被识别的隐匿性转移性疾病的识别,有助于避免不必要的手术。